Information for "YKL40 necessary protein term in individual cancer trials along with man tumor cell series xenografts implications because of its used in growth types"
From EECH Central
Basic information
Display title | YKL40 necessary protein term in individual cancer trials along with man tumor cell series xenografts implications because of its used in growth types |
Default sort key | YKL40 necessary protein term in individual cancer trials along with man tumor cell series xenografts implications because of its used in growth types |
Page length (in bytes) | 3,442 |
Page ID | 1420071 |
Page content language | English (en) |
Page content model | wikitext |
Indexing by robots | Allowed |
Number of redirects to this page | 0 |
Page protection
Edit | Allow all users (infinite) |
Move | Allow all users (infinite) |
Edit history
Page creator | Greenbaker5 (Talk | contribs) |
Date of page creation | 11:51, 29 April 2024 |
Latest editor | Greenbaker5 (Talk | contribs) |
Date of latest edit | 11:51, 29 April 2024 |
Total number of edits | 1 |
Total number of distinct authors | 1 |
Recent number of edits (within past 90 days) | 1 |
Recent number of distinct authors | 1 |